Market Quick Take - November 30, 2020 Market Quick Take - November 30, 2020 Market Quick Take - November 30, 2020

Market Quick Take - November 30, 2020

Macro 6 minutes to read
John Hardy

Head of FX Strategy

Summary:  Markets have started the week in defensive mode after a strong close to trading last week. Safe haven bond yields suggest a defensive stance since late last week, although equity markets have not corroborated this until the Asian session overnight. A bit of end-of-month rebalancing on this last day of the month, perhaps? That would certainly not be a major surprise, given that this month will likely prove the strongest single month in global equity market history.


What is our trading focus?

  • Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I) - US equities are 0.7% lower this morning following news that the Trump administration will most likely add two more Chinese companies SMIC and CNOOC to its defense blacklist. In S&P 500 futures the next important support level is around 3,600 and given the tensions with China and the fact that this month has been one of the best for global equities we guess that risk-off will prevail during the entire session. Nasdaq 100 futures seem to be less responding to the US-China tensions down only half as much as S&P 500 futures.

  • Bitcoin Tracker ETN (BITCOIN_XBTE:xome) and Ethereum Tracker ETN (ETHEREUM_XBTE:xome) - Bitcoin and Ethereum have managed to shake off a good portion of the volatility that suddenly arrived last week on the heels of concerns expressed on the risk of regulation, triggering a significant consolidation of recent gains. It is likely no coincidence that the consolidation took place right up against the all-time highs north of 19,500 in Bitcoin, as 20,000 is likely a major psychological focus for whether further upside gains will be unlocked from here.

  • EURUSD – EURUSD pulled higher for its strongest daily and weekly close since early 2018, with 1.2000 now clearly in its sights. The big round levels in EURUSD have long provided major sticking points and that has been no exception this year, with the probe of 1.2000 back in September. The more the outlook points to hopes that authorities can roll out a Covid-19 vaccine and an improved growth outlook, the more ammunition for the bulls looking for 1.2000 to fall and open the way for the early 2018 highs above 1.2500 (again, that was the final resistance level of the rally at the time, with no weekly closes above that level despite three tries on three different weeks above).

  • AUDUSD – the Aussie is a currency worth watching as AUDUSD approaches the cycle high just above 0.7400 and as we consider the risk to the Australian economy on a confrontation with China over its policies with that country, which drives a significant portion of demand for Australian exports. The tension ratcheted higher at the weekend with China’s move to slap tariffs on Australian wine imports (more below.)

  • China A50 Dec (CNZ0) - the index was up as much as 2% at one point during the session before the news about the US likely adding SMIC and CNOOC to its defense blacklist but is now down almost 1% for the day. Hang Seng futures in Hong Kong are down 1.6%. Other emerging markets are down with South Korean equities down almost 2%.

  • Brent crude oil (OILUKJAN21) and WTI crude oil (OILUSJAN21) trade lower ahead of today’s OPEC and Tuesdays OPEC+ meetings. This after an informal online discussion Sunday evening failed to agree on a postponement of the January 1.9 million barrel/day production hike. Failure to curb production amid an ongoing pandemic and the positive impact on demand from a vaccine rollout still month away could hurt the price. Thereby triggering an exodus of the some of the +100 million barrels that speculators have bought in Brent alone this month.

  • Gold (XAUUSD) and silver (XAGUSD) both struggle while HG Copper (COPPERUSMAR21) continues to surge higher, reaching a seven-year high in Asia overnight. The vaccine-led change in focus from safe-haven to growth has triggered sharp adjustments this month, culminating in a the 6-million-ounce clear-out Friday below $1800/oz. Overnight in Asia it almost touched the next key support at $1763.50/oz, the 50% retracement of the March to August surge. Silver meanwhile has yet to challenge the September low at $21.68/oz. The fact the latest selloff occurred despite a weaker dollar and lower real yields highlights the current focus on vaccines and their expected market impact in 2021.

  • Portuguese sovereigns will consolidate below 0% in yield this week, the periphery will continue its rally (FBONZ0, 10YBTPDEC2020). Portuguese 10-year sovereigns will most likely consolidate below 0% in yield this week and the periphery will continue to rally. Even though Spanish sovereigns are next in line to fall below 0%, we still believe that biggest upside is to be found in 30-year Italian BTPs as they trade rich compared to its peers.

  • Junk continues to rise as the market is looking for higher yields (HYG:arcx). US junk credits are near to recover their Covid-19 losses. Year to date, the market has seen $406 billions of high yield credits new issuances versus $288 billions compared to 2019. Junk corporates are taking advantage of ever low rates to issue and extend their debt.

What is going on?

  • US places two large Chinese companies on its blacklist linking the move to China’s activity in oil exploration and drilling in the disputed areas of the South China Sea, the US has placed CNOOC, the third-largest oil company in China, on its black-list of companies with links to the Chinese military. The company’s stock was down some 10% overnight. The other company black-listed by the US is Chinese semi-conductor maker SMIC, which relies on many US semi-conductor companies for its supplies.

  • The EU is set to pitch the US on an alliance to face “strategic challenge” posed by China – clearly timed in anticipation of the end of the unilateral Trump era, the EU is set to make a major diplomatic push to create an alliance with the US in facing the “strategic challenge” presented by China, and aligning on matters like digital regulation, the tackling of the Covid-19 pandemic and environmental issues. A draft document was seen by the FT. The EU is open to Joe Biden’s call for a “summit of democracies”.

What we are watching next?

  • Germany Flash November CPI up today – and is expected to show a reading of –0.7% month-on-month and –0.2% year-on-year, the latter unchanged from the prior month’s reading. Three of the last four year-on-year CPI readings have been negative. With year-on-year comparisons for oil prices set to look far less deflationary starting in March, the negative readings may not linger, but debt loads in Germany and across the Euro Zone mean that the disinflation and weak growth are a real threat for the ECB’s mandate.

  • Brexit breakthrough news – is this week really “the final week for negotiations”? As we enter this week, we have the confusing combination of rather positive developments in the latest round of Brexit talks – particularly on the fisheries issue, where an agreement on a transition period may be in the works – but sterling doesn’t seem particularly inspired, and EURGBP has drifted back higher toward the 0.9000 area. Talks are set to resume today, and this week has been billed as a “final week” for reaching an agreement (or will we actually get a delay of sorts despite Boris Johnson’s promise not to do so – or even get both, an agreement framework, with a delay on the details...).

Earnings releases this week are running low as we are off season. But the releases below are worth following:

  • Monday: Meituan, Immunomedics, Sino Biopharmaceutical
  • Tuesday: Bank of Nova Scotia, Bank of Montreal, Salesforce, Veeva Systems, Trip.com
  • Wednesday: Royal Bank of Canada, National Bank of Canada, Snowflake, Synopsys, Crowdstrike, Splunk, Okta, Zscaler
  • Thursday: DocuSign, Marvell Technology, Dollar General, Kroger

Economic Calendar Highlights for today (times GMT)

  • 0930 – UK Oct. Mortgage Approvals
  • 1000 – ECB President Lagarde to Speak
  • 1300 – Germany Nov. Flash CPI
  • 1330 – Canada Oct. Building Permits
  • 1445 – US Nov. Chicago PMI
  • During the day – OPEC virtual meeting
  • 0330 – Australia RBA Cash Target announcement

Follow SaxoStrats on the daily Saxo Markets Call on your favorite podcast app:

Apple Sportify Soundcloud Stitcher

Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.